# A Study of [14C]GB491 in Male Healthy Subjects

> **NCT05860582** · PHASE1 · COMPLETED · sponsor: **Genor Biopharma Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Breast Cancer
- Nonsmall Cell Lung Cancer

## Interventions

- **DRUG:** [14C]GB491

## Key facts

- **NCT ID:** NCT05860582
- **Lead sponsor:** Genor Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-14
- **Primary completion:** 2022-11-14
- **Final completion:** 2022-11-14
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05860582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05860582, "A Study of [14C]GB491 in Male Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05860582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*